455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Market cap: $1.3B (2/10/2026)
Price: $66.33
Nektar Therapeutics Reports $229.1 Million in Cash and Investments
Investor Presentation
News
Chief Legal Officer Departure - Mark A. Wilson Steps Down at Nektar
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
Reports Third Quarter 2025 Financial Results
Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities